Lubiprostone
NDC 65162-842, Lubiprostone, capsule, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-842
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209450
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65162-842 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LUBIPROSTONE24 ug/1
Pharmacologic classes
Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-842-06 | 65162084206 | 60 CAPSULE in 1 BOTTLE (65162-842-06) |
| 65162-842-18 | 65162084218 | 180 CAPSULE in 1 BOTTLE (65162-842-18) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/333acede-5075-464f-9418-4b22d43eef3c
Use it
Look up 65162-842 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-842 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-842. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.